| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adiposity and sex-specific cancer risk
|
Rask-Andersen, Mathias
|
|
|
41 |
6 |
p. 1186-1197.e4
|
artikel
|
| 2 |
Calreticulin exposure orchestrates innate immunosurveillance
|
Guilbaud, Emma
|
|
|
41 |
6 |
p. 1014-1016
|
artikel
|
| 3 |
CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis
|
Minami, Jenna K.
|
|
|
41 |
6 |
p. 1048-1060.e9
|
artikel
|
| 4 |
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
|
Magbanua, Mark Jesus M.
|
|
|
41 |
6 |
p. 1091-1102.e4
|
artikel
|
| 5 |
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity
|
Liu, Xiuting
|
|
|
41 |
6 |
p. 1073-1090.e12
|
artikel
|
| 6 |
Decoding evolutionary trajectories of ovarian cancer metastasis
|
Shimizu, Aasa
|
|
|
41 |
6 |
p. 1008-1010
|
artikel
|
| 7 |
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population
|
van Zeventer, Isabelle A.
|
|
|
41 |
6 |
p. 1017-1031.e4
|
artikel
|
| 8 |
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
|
Lahtinen, Alexandra
|
|
|
41 |
6 |
p. 1103-1117.e12
|
artikel
|
| 9 |
Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer
|
Ma, Brigette B.Y.
|
|
|
41 |
6 |
p. 1006-1008
|
artikel
|
| 10 |
Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity
|
Fang, Lan
|
|
|
41 |
6 |
p. 1118-1133.e12
|
artikel
|
| 11 |
RECISTv1.1 progression in oncology: Shades of gray
|
Topp, Brian
|
|
|
41 |
6 |
p. 1003-1005
|
artikel
|
| 12 |
Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer
|
Li, Jianxia
|
|
|
41 |
6 |
p. 1152-1169.e7
|
artikel
|
| 13 |
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
|
Zhang, Xinwei
|
|
|
41 |
6 |
p. 1198
|
artikel
|
| 14 |
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease
|
Dang, Minghao
|
|
|
41 |
6 |
p. 1032-1047.e4
|
artikel
|
| 15 |
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
|
Ramachandran, Mohanraj
|
|
|
41 |
6 |
p. 1134-1151.e10
|
artikel
|
| 16 |
Taxanes directly induce T cell cytotoxic extracellular vesicles to eradicate tumor cells
|
Xu, Ying
|
|
|
41 |
6 |
p. 1011-1013
|
artikel
|
| 17 |
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
|
Vennin, Claire
|
|
|
41 |
6 |
p. 1170-1185.e12
|
artikel
|
| 18 |
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
|
Yang, Yunpeng
|
|
|
41 |
6 |
p. 1061-1072.e4
|
artikel
|
Tijdschrift beschrijving